Over the past several weeks, acquisition announcements have arrived at a rapid pace across the industry. Between transactions involving Medtronic, ResMed, Artivion, and Roche, nearly $2 billion in deal value has been announced in a short period of time. The headlines naturally raise a question: is this a true surge in medtech M&A, or are a handful of high-profile deals creating that impression? A review of recent transactions, combined with activity tracked in Compass AI, suggests that strategic buyers remain highly active. However, the broader data indicate a market that is accelerating within an established trend rather than entering entirely new territory.
Read the full article: Medtech M&A Activity Is Rising, But Is It Really a Boom? //
Source: https://www.lifesciencemarketresearch.com/insights/medtech-ma-activity-is-rising-but-is-it-really-a-boom